nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—DCK—Purine salvage—PNP—osteoporosis	0.0505	0.333	CbGpPWpGaD
Emtricitabine—DCK—Purine metabolism—ATIC—osteoporosis	0.024	0.158	CbGpPWpGaD
Emtricitabine—DCK—Purine metabolism—PNP—osteoporosis	0.024	0.158	CbGpPWpGaD
Emtricitabine—DCK—Nucleotide metabolism—PNP—osteoporosis	0.012	0.0795	CbGpPWpGaD
Emtricitabine—DCK—Nucleotide metabolism—ATIC—osteoporosis	0.012	0.0795	CbGpPWpGaD
Emtricitabine—DCK—Purine metabolism—GPX1—osteoporosis	0.00679	0.0448	CbGpPWpGaD
Emtricitabine—DCK—Fulvestrant—Estradiol—osteoporosis	0.00483	0.261	CbGdCrCtD
Emtricitabine—DCK—Estradiol valerate/Dienogest—Estradiol—osteoporosis	0.00452	0.245	CbGdCrCtD
Emtricitabine—DCK—Estradiol valerate/Dienogest—Ethinyl Estradiol—osteoporosis	0.00442	0.239	CbGdCrCtD
Emtricitabine—DCK—Nucleotide metabolism—GPX1—osteoporosis	0.00341	0.0225	CbGpPWpGaD
Emtricitabine—DCK—Levorphanol—Estradiol—osteoporosis	0.00319	0.173	CbGdCrCtD
Emtricitabine—DCK—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00151	0.0818	CbGdCrCtD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.00133	0.0088	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PKM—osteoporosis	0.00126	0.00833	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—FDPS—osteoporosis	0.00126	0.00833	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PGLS—osteoporosis	0.0012	0.00789	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—GPD2—osteoporosis	0.0012	0.00789	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PNP—osteoporosis	0.00109	0.00722	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—ATIC—osteoporosis	0.00109	0.00722	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—CA2—osteoporosis	0.00093	0.00614	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—OXCT1—osteoporosis	0.00093	0.00614	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—MGLL—osteoporosis	0.000906	0.00598	CbGpPWpGaD
Emtricitabine—Pain—Calcitriol—osteoporosis	0.000897	0.00108	CcSEcCtD
Emtricitabine—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000888	0.00107	CcSEcCtD
Emtricitabine—Urticaria—Estropipate—osteoporosis	0.000888	0.00107	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Raloxifene—osteoporosis	0.000885	0.00107	CcSEcCtD
Emtricitabine—Diarrhoea—Etidronic acid—osteoporosis	0.000884	0.00106	CcSEcCtD
Emtricitabine—Haematuria—Estradiol—osteoporosis	0.000883	0.00106	CcSEcCtD
Emtricitabine—Body temperature increased—Estropipate—osteoporosis	0.000883	0.00106	CcSEcCtD
Emtricitabine—Abdominal pain—Estropipate—osteoporosis	0.000883	0.00106	CcSEcCtD
Emtricitabine—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00088	0.00106	CcSEcCtD
Emtricitabine—Infection—Risedronate—osteoporosis	0.000877	0.00106	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Estradiol—osteoporosis	0.000876	0.00106	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Ibandronate—osteoporosis	0.000876	0.00106	CcSEcCtD
Emtricitabine—Arthralgia—Pamidronate—osteoporosis	0.000876	0.00105	CcSEcCtD
Emtricitabine—Myalgia—Pamidronate—osteoporosis	0.000876	0.00105	CcSEcCtD
Emtricitabine—Back pain—Conjugated Estrogens—osteoporosis	0.000875	0.00105	CcSEcCtD
Emtricitabine—Urticaria—Alendronate—osteoporosis	0.000874	0.00105	CcSEcCtD
Emtricitabine—Anxiety—Pamidronate—osteoporosis	0.000873	0.00105	CcSEcCtD
Emtricitabine—Abdominal pain—Alendronate—osteoporosis	0.00087	0.00105	CcSEcCtD
Emtricitabine—Body temperature increased—Alendronate—osteoporosis	0.00087	0.00105	CcSEcCtD
Emtricitabine—Sinusitis—Estradiol—osteoporosis	0.000869	0.00105	CcSEcCtD
Emtricitabine—Anaemia—Zoledronate—osteoporosis	0.000868	0.00105	CcSEcCtD
Emtricitabine—Nervous system disorder—Risedronate—osteoporosis	0.000866	0.00104	CcSEcCtD
Emtricitabine—Angioedema—Zoledronate—osteoporosis	0.000858	0.00103	CcSEcCtD
Emtricitabine—Skin disorder—Risedronate—osteoporosis	0.000858	0.00103	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Calcitriol—osteoporosis	0.000858	0.00103	CcSEcCtD
Emtricitabine—Body temperature increased—Raloxifene—osteoporosis	0.000856	0.00103	CcSEcCtD
Emtricitabine—Abdominal pain—Raloxifene—osteoporosis	0.000856	0.00103	CcSEcCtD
Emtricitabine—Urticaria—Ibandronate—osteoporosis	0.000851	0.00103	CcSEcCtD
Emtricitabine—Abdominal pain—Ibandronate—osteoporosis	0.000847	0.00102	CcSEcCtD
Emtricitabine—Body temperature increased—Ibandronate—osteoporosis	0.000847	0.00102	CcSEcCtD
Emtricitabine—Infection—Pamidronate—osteoporosis	0.000834	0.001	CcSEcCtD
Emtricitabine—Rhinitis—Estradiol—osteoporosis	0.000834	0.001	CcSEcCtD
Emtricitabine—Urticaria—Calcitriol—osteoporosis	0.000833	0.001	CcSEcCtD
Emtricitabine—Hepatitis—Estradiol—osteoporosis	0.000832	0.001	CcSEcCtD
Emtricitabine—Abdominal pain—Calcitriol—osteoporosis	0.000829	0.000999	CcSEcCtD
Emtricitabine—Body temperature increased—Calcitriol—osteoporosis	0.000829	0.000999	CcSEcCtD
Emtricitabine—Angioedema—Conjugated Estrogens—osteoporosis	0.000827	0.000996	CcSEcCtD
Emtricitabine—Pharyngitis—Estradiol—osteoporosis	0.000825	0.000994	CcSEcCtD
Emtricitabine—Hypersensitivity—Estropipate—osteoporosis	0.000823	0.000992	CcSEcCtD
Emtricitabine—Nervous system disorder—Pamidronate—osteoporosis	0.000823	0.000992	CcSEcCtD
Emtricitabine—Thrombocytopenia—Pamidronate—osteoporosis	0.000822	0.00099	CcSEcCtD
Emtricitabine—Urinary tract disorder—Estradiol—osteoporosis	0.000821	0.000989	CcSEcCtD
Emtricitabine—Vomiting—Etidronic acid—osteoporosis	0.000821	0.000989	CcSEcCtD
Emtricitabine—Cough—Zoledronate—osteoporosis	0.00082	0.000988	CcSEcCtD
Emtricitabine—Connective tissue disorder—Estradiol—osteoporosis	0.000817	0.000985	CcSEcCtD
Emtricitabine—Urethral disorder—Estradiol—osteoporosis	0.000815	0.000982	CcSEcCtD
Emtricitabine—Rash—Etidronic acid—osteoporosis	0.000814	0.000981	CcSEcCtD
Emtricitabine—Dermatitis—Etidronic acid—osteoporosis	0.000814	0.00098	CcSEcCtD
Emtricitabine—Hypersensitivity—Alendronate—osteoporosis	0.000811	0.000977	CcSEcCtD
Emtricitabine—Headache—Etidronic acid—osteoporosis	0.000809	0.000975	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000804	0.000969	CcSEcCtD
Emtricitabine—Asthenia—Estropipate—osteoporosis	0.000802	0.000966	CcSEcCtD
Emtricitabine—Arthralgia—Zoledronate—osteoporosis	0.0008	0.000964	CcSEcCtD
Emtricitabine—Myalgia—Zoledronate—osteoporosis	0.0008	0.000964	CcSEcCtD
Emtricitabine—Insomnia—Risedronate—osteoporosis	0.000799	0.000962	CcSEcCtD
Emtricitabine—Anxiety—Zoledronate—osteoporosis	0.000797	0.00096	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000794	0.000957	CcSEcCtD
Emtricitabine—Paraesthesia—Risedronate—osteoporosis	0.000793	0.000955	CcSEcCtD
Emtricitabine—Pruritus—Estropipate—osteoporosis	0.00079	0.000952	CcSEcCtD
Emtricitabine—Asthenia—Alendronate—osteoporosis	0.00079	0.000951	CcSEcCtD
Emtricitabine—Hypersensitivity—Ibandronate—osteoporosis	0.000789	0.000951	CcSEcCtD
Emtricitabine—Cough—Conjugated Estrogens—osteoporosis	0.000789	0.000951	CcSEcCtD
Emtricitabine—Dyspnoea—Risedronate—osteoporosis	0.000787	0.000948	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000782	0.000942	CcSEcCtD
Emtricitabine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000781	0.000941	CcSEcCtD
Emtricitabine—Pruritus—Alendronate—osteoporosis	0.000779	0.000938	CcSEcCtD
Emtricitabine—Dyspepsia—Risedronate—osteoporosis	0.000777	0.000936	CcSEcCtD
Emtricitabine—Hypersensitivity—Calcitriol—osteoporosis	0.000773	0.000931	CcSEcCtD
Emtricitabine—DCK—Metabolism—IDH2—osteoporosis	0.000771	0.00509	CbGpPWpGaD
Emtricitabine—Arthralgia—Conjugated Estrogens—osteoporosis	0.00077	0.000928	CcSEcCtD
Emtricitabine—Myalgia—Conjugated Estrogens—osteoporosis	0.00077	0.000928	CcSEcCtD
Emtricitabine—Asthenia—Ibandronate—osteoporosis	0.000769	0.000926	CcSEcCtD
Emtricitabine—Anxiety—Conjugated Estrogens—osteoporosis	0.000767	0.000925	CcSEcCtD
Emtricitabine—Nausea—Etidronic acid—osteoporosis	0.000767	0.000924	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000765	0.000921	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000765	0.000921	CcSEcCtD
Emtricitabine—Diarrhoea—Estropipate—osteoporosis	0.000764	0.000921	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000762	0.000918	CcSEcCtD
Emtricitabine—Infection—Zoledronate—osteoporosis	0.000762	0.000918	CcSEcCtD
Emtricitabine—Fatigue—Risedronate—osteoporosis	0.000761	0.000917	CcSEcCtD
Emtricitabine—Insomnia—Pamidronate—osteoporosis	0.000759	0.000915	CcSEcCtD
Emtricitabine—Pruritus—Ibandronate—osteoporosis	0.000758	0.000913	CcSEcCtD
Emtricitabine—Pain—Risedronate—osteoporosis	0.000755	0.00091	CcSEcCtD
Emtricitabine—Paraesthesia—Pamidronate—osteoporosis	0.000754	0.000908	CcSEcCtD
Emtricitabine—Diarrhoea—Alendronate—osteoporosis	0.000753	0.000907	CcSEcCtD
Emtricitabine—Asthenia—Calcitriol—osteoporosis	0.000752	0.000907	CcSEcCtD
Emtricitabine—Nervous system disorder—Zoledronate—osteoporosis	0.000752	0.000906	CcSEcCtD
Emtricitabine—Immune system disorder—Estradiol—osteoporosis	0.000751	0.000905	CcSEcCtD
Emtricitabine—Thrombocytopenia—Zoledronate—osteoporosis	0.000751	0.000904	CcSEcCtD
Emtricitabine—Mediastinal disorder—Estradiol—osteoporosis	0.00075	0.000903	CcSEcCtD
Emtricitabine—Dyspnoea—Pamidronate—osteoporosis	0.000748	0.000902	CcSEcCtD
Emtricitabine—Skin disorder—Zoledronate—osteoporosis	0.000745	0.000897	CcSEcCtD
Emtricitabine—Pruritus—Calcitriol—osteoporosis	0.000742	0.000894	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000741	0.000892	CcSEcCtD
Emtricitabine—Diarrhoea—Raloxifene—osteoporosis	0.00074	0.000892	CcSEcCtD
Emtricitabine—Dyspepsia—Pamidronate—osteoporosis	0.000739	0.00089	CcSEcCtD
Emtricitabine—Dizziness—Estropipate—osteoporosis	0.000739	0.00089	CcSEcCtD
Emtricitabine—Infection—Conjugated Estrogens—osteoporosis	0.000733	0.000884	CcSEcCtD
Emtricitabine—Diarrhoea—Ibandronate—osteoporosis	0.000733	0.000883	CcSEcCtD
Emtricitabine—Mental disorder—Estradiol—osteoporosis	0.000729	0.000878	CcSEcCtD
Emtricitabine—Dizziness—Alendronate—osteoporosis	0.000728	0.000877	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000725	0.000873	CcSEcCtD
Emtricitabine—DCK—Metabolism—CYP27A1—osteoporosis	0.000724	0.00478	CbGpPWpGaD
Emtricitabine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000724	0.000872	CcSEcCtD
Emtricitabine—Malnutrition—Estradiol—osteoporosis	0.000724	0.000872	CcSEcCtD
Emtricitabine—Fatigue—Pamidronate—osteoporosis	0.000724	0.000872	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Risedronate—osteoporosis	0.000722	0.00087	CcSEcCtD
Emtricitabine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000719	0.000867	CcSEcCtD
Emtricitabine—Pain—Pamidronate—osteoporosis	0.000718	0.000865	CcSEcCtD
Emtricitabine—Diarrhoea—Calcitriol—osteoporosis	0.000718	0.000865	CcSEcCtD
Emtricitabine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000717	0.000864	CcSEcCtD
Emtricitabine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000716	0.000862	CcSEcCtD
Emtricitabine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000716	0.000862	CcSEcCtD
Emtricitabine—Dizziness—Raloxifene—osteoporosis	0.000716	0.000862	CcSEcCtD
Emtricitabine—Vomiting—Estropipate—osteoporosis	0.00071	0.000856	CcSEcCtD
Emtricitabine—Dizziness—Ibandronate—osteoporosis	0.000708	0.000854	CcSEcCtD
Emtricitabine—DCK—Metabolism—ACP5—osteoporosis	0.000705	0.00465	CbGpPWpGaD
Emtricitabine—Rash—Estropipate—osteoporosis	0.000704	0.000849	CcSEcCtD
Emtricitabine—Dermatitis—Estropipate—osteoporosis	0.000704	0.000848	CcSEcCtD
Emtricitabine—Urticaria—Risedronate—osteoporosis	0.000701	0.000845	CcSEcCtD
Emtricitabine—Back pain—Estradiol—osteoporosis	0.0007	0.000844	CcSEcCtD
Emtricitabine—Headache—Estropipate—osteoporosis	0.0007	0.000843	CcSEcCtD
Emtricitabine—Vomiting—Alendronate—osteoporosis	0.0007	0.000843	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000699	0.000842	CcSEcCtD
Emtricitabine—Abdominal pain—Risedronate—osteoporosis	0.000698	0.000841	CcSEcCtD
Emtricitabine—Body temperature increased—Risedronate—osteoporosis	0.000698	0.000841	CcSEcCtD
Emtricitabine—Rash—Alendronate—osteoporosis	0.000694	0.000836	CcSEcCtD
Emtricitabine—Insomnia—Zoledronate—osteoporosis	0.000693	0.000835	CcSEcCtD
Emtricitabine—Dermatitis—Alendronate—osteoporosis	0.000693	0.000835	CcSEcCtD
Emtricitabine—Headache—Alendronate—osteoporosis	0.000689	0.000831	CcSEcCtD
Emtricitabine—Paraesthesia—Zoledronate—osteoporosis	0.000688	0.000829	CcSEcCtD
Emtricitabine—Vomiting—Raloxifene—osteoporosis	0.000688	0.000829	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000686	0.000827	CcSEcCtD
Emtricitabine—Dyspnoea—Zoledronate—osteoporosis	0.000684	0.000823	CcSEcCtD
Emtricitabine—Rash—Raloxifene—osteoporosis	0.000682	0.000822	CcSEcCtD
Emtricitabine—Dermatitis—Raloxifene—osteoporosis	0.000682	0.000821	CcSEcCtD
Emtricitabine—Vomiting—Ibandronate—osteoporosis	0.000681	0.000821	CcSEcCtD
Emtricitabine—Headache—Raloxifene—osteoporosis	0.000678	0.000817	CcSEcCtD
Emtricitabine—Rash—Ibandronate—osteoporosis	0.000676	0.000814	CcSEcCtD
Emtricitabine—Dermatitis—Ibandronate—osteoporosis	0.000675	0.000813	CcSEcCtD
Emtricitabine—Dyspepsia—Zoledronate—osteoporosis	0.000675	0.000813	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000673	0.00081	CcSEcCtD
Emtricitabine—Headache—Ibandronate—osteoporosis	0.000671	0.000809	CcSEcCtD
Emtricitabine—Insomnia—Conjugated Estrogens—osteoporosis	0.000668	0.000804	CcSEcCtD
Emtricitabine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000667	0.000804	CcSEcCtD
Emtricitabine—Vomiting—Calcitriol—osteoporosis	0.000667	0.000803	CcSEcCtD
Emtricitabine—Nausea—Estropipate—osteoporosis	0.000664	0.0008	CcSEcCtD
Emtricitabine—Body temperature increased—Pamidronate—osteoporosis	0.000664	0.000799	CcSEcCtD
Emtricitabine—Abdominal pain—Pamidronate—osteoporosis	0.000664	0.000799	CcSEcCtD
Emtricitabine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000663	0.000799	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000662	0.000797	CcSEcCtD
Emtricitabine—Angioedema—Estradiol—osteoporosis	0.000661	0.000797	CcSEcCtD
Emtricitabine—Rash—Calcitriol—osteoporosis	0.000661	0.000797	CcSEcCtD
Emtricitabine—Fatigue—Zoledronate—osteoporosis	0.000661	0.000796	CcSEcCtD
Emtricitabine—Dermatitis—Calcitriol—osteoporosis	0.000661	0.000796	CcSEcCtD
Emtricitabine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000658	0.000793	CcSEcCtD
Emtricitabine—Headache—Calcitriol—osteoporosis	0.000657	0.000792	CcSEcCtD
Emtricitabine—Pain—Zoledronate—osteoporosis	0.000656	0.00079	CcSEcCtD
Emtricitabine—DCK—Metabolism—TPI1—osteoporosis	0.000655	0.00433	CbGpPWpGaD
Emtricitabine—Nausea—Alendronate—osteoporosis	0.000654	0.000787	CcSEcCtD
Emtricitabine—Hypersensitivity—Risedronate—osteoporosis	0.000651	0.000784	CcSEcCtD
Emtricitabine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00065	0.000783	CcSEcCtD
Emtricitabine—Asthenia—Ethinyl Estradiol—osteoporosis	0.00065	0.000783	CcSEcCtD
Emtricitabine—Nausea—Raloxifene—osteoporosis	0.000643	0.000774	CcSEcCtD
Emtricitabine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000641	0.000772	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000637	0.000768	CcSEcCtD
Emtricitabine—Fatigue—Conjugated Estrogens—osteoporosis	0.000636	0.000767	CcSEcCtD
Emtricitabine—Nausea—Ibandronate—osteoporosis	0.000636	0.000767	CcSEcCtD
Emtricitabine—Asthenia—Risedronate—osteoporosis	0.000633	0.000763	CcSEcCtD
Emtricitabine—Cough—Estradiol—osteoporosis	0.000632	0.000761	CcSEcCtD
Emtricitabine—Pain—Conjugated Estrogens—osteoporosis	0.000631	0.000761	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000627	0.000755	CcSEcCtD
Emtricitabine—Pruritus—Risedronate—osteoporosis	0.000625	0.000753	CcSEcCtD
Emtricitabine—Nausea—Calcitriol—osteoporosis	0.000623	0.000751	CcSEcCtD
Emtricitabine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00062	0.000746	CcSEcCtD
Emtricitabine—Hypersensitivity—Pamidronate—osteoporosis	0.000618	0.000745	CcSEcCtD
Emtricitabine—Arthralgia—Estradiol—osteoporosis	0.000616	0.000743	CcSEcCtD
Emtricitabine—Myalgia—Estradiol—osteoporosis	0.000616	0.000743	CcSEcCtD
Emtricitabine—DCK—Metabolism—P4HB—osteoporosis	0.000616	0.00407	CbGpPWpGaD
Emtricitabine—Anxiety—Estradiol—osteoporosis	0.000614	0.00074	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000612	0.000737	CcSEcCtD
Emtricitabine—Urticaria—Zoledronate—osteoporosis	0.000609	0.000734	CcSEcCtD
Emtricitabine—Abdominal pain—Zoledronate—osteoporosis	0.000606	0.00073	CcSEcCtD
Emtricitabine—Body temperature increased—Zoledronate—osteoporosis	0.000606	0.00073	CcSEcCtD
Emtricitabine—DCK—Metabolism—GAPDH—osteoporosis	0.000605	0.00399	CbGpPWpGaD
Emtricitabine—Diarrhoea—Risedronate—osteoporosis	0.000604	0.000728	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000604	0.000727	CcSEcCtD
Emtricitabine—Asthenia—Pamidronate—osteoporosis	0.000602	0.000726	CcSEcCtD
Emtricitabine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000599	0.000721	CcSEcCtD
Emtricitabine—Pruritus—Pamidronate—osteoporosis	0.000594	0.000715	CcSEcCtD
Emtricitabine—DCK—Metabolism—RAP1A—osteoporosis	0.000589	0.00389	CbGpPWpGaD
Emtricitabine—Infection—Estradiol—osteoporosis	0.000587	0.000707	CcSEcCtD
Emtricitabine—Urticaria—Conjugated Estrogens—osteoporosis	0.000586	0.000707	CcSEcCtD
Emtricitabine—Dizziness—Risedronate—osteoporosis	0.000584	0.000703	CcSEcCtD
Emtricitabine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000584	0.000703	CcSEcCtD
Emtricitabine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000584	0.000703	CcSEcCtD
Emtricitabine—Nervous system disorder—Estradiol—osteoporosis	0.000579	0.000698	CcSEcCtD
Emtricitabine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000576	0.000694	CcSEcCtD
Emtricitabine—Diarrhoea—Pamidronate—osteoporosis	0.000574	0.000692	CcSEcCtD
Emtricitabine—Skin disorder—Estradiol—osteoporosis	0.000574	0.000691	CcSEcCtD
Emtricitabine—Rash—Ethinyl Estradiol—osteoporosis	0.000571	0.000688	CcSEcCtD
Emtricitabine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00057	0.000687	CcSEcCtD
Emtricitabine—Headache—Ethinyl Estradiol—osteoporosis	0.000567	0.000683	CcSEcCtD
Emtricitabine—Hypersensitivity—Zoledronate—osteoporosis	0.000565	0.000681	CcSEcCtD
Emtricitabine—Vomiting—Risedronate—osteoporosis	0.000561	0.000676	CcSEcCtD
Emtricitabine—Rash—Risedronate—osteoporosis	0.000557	0.000671	CcSEcCtD
Emtricitabine—Dermatitis—Risedronate—osteoporosis	0.000556	0.00067	CcSEcCtD
Emtricitabine—Dizziness—Pamidronate—osteoporosis	0.000555	0.000669	CcSEcCtD
Emtricitabine—Headache—Risedronate—osteoporosis	0.000553	0.000666	CcSEcCtD
Emtricitabine—Asthenia—Zoledronate—osteoporosis	0.00055	0.000663	CcSEcCtD
Emtricitabine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000544	0.000655	CcSEcCtD
Emtricitabine—Pruritus—Zoledronate—osteoporosis	0.000542	0.000653	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000538	0.000649	CcSEcCtD
Emtricitabine—Nausea—Ethinyl Estradiol—osteoporosis	0.000538	0.000648	CcSEcCtD
Emtricitabine—Insomnia—Estradiol—osteoporosis	0.000534	0.000644	CcSEcCtD
Emtricitabine—Vomiting—Pamidronate—osteoporosis	0.000534	0.000643	CcSEcCtD
Emtricitabine—Paraesthesia—Estradiol—osteoporosis	0.000531	0.000639	CcSEcCtD
Emtricitabine—Asthenia—Conjugated Estrogens—osteoporosis	0.00053	0.000638	CcSEcCtD
Emtricitabine—Rash—Pamidronate—osteoporosis	0.000529	0.000638	CcSEcCtD
Emtricitabine—Dermatitis—Pamidronate—osteoporosis	0.000529	0.000637	CcSEcCtD
Emtricitabine—Dyspnoea—Estradiol—osteoporosis	0.000527	0.000635	CcSEcCtD
Emtricitabine—Headache—Pamidronate—osteoporosis	0.000526	0.000633	CcSEcCtD
Emtricitabine—Diarrhoea—Zoledronate—osteoporosis	0.000525	0.000632	CcSEcCtD
Emtricitabine—Nausea—Risedronate—osteoporosis	0.000524	0.000632	CcSEcCtD
Emtricitabine—Pruritus—Conjugated Estrogens—osteoporosis	0.000522	0.000629	CcSEcCtD
Emtricitabine—Dyspepsia—Estradiol—osteoporosis	0.00052	0.000627	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Estradiol—osteoporosis	0.00051	0.000615	CcSEcCtD
Emtricitabine—Fatigue—Estradiol—osteoporosis	0.000509	0.000614	CcSEcCtD
Emtricitabine—Dizziness—Zoledronate—osteoporosis	0.000507	0.000611	CcSEcCtD
Emtricitabine—Pain—Estradiol—osteoporosis	0.000505	0.000609	CcSEcCtD
Emtricitabine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000505	0.000609	CcSEcCtD
Emtricitabine—Nausea—Pamidronate—osteoporosis	0.000499	0.000601	CcSEcCtD
Emtricitabine—Dizziness—Conjugated Estrogens—osteoporosis	0.000488	0.000588	CcSEcCtD
Emtricitabine—Vomiting—Zoledronate—osteoporosis	0.000487	0.000587	CcSEcCtD
Emtricitabine—Rash—Zoledronate—osteoporosis	0.000483	0.000582	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Estradiol—osteoporosis	0.000483	0.000582	CcSEcCtD
Emtricitabine—Dermatitis—Zoledronate—osteoporosis	0.000483	0.000582	CcSEcCtD
Emtricitabine—Headache—Zoledronate—osteoporosis	0.00048	0.000579	CcSEcCtD
Emtricitabine—DCK—Metabolism—ENO1—osteoporosis	0.000476	0.00314	CbGpPWpGaD
Emtricitabine—Vomiting—Conjugated Estrogens—osteoporosis	0.000469	0.000565	CcSEcCtD
Emtricitabine—Urticaria—Estradiol—osteoporosis	0.000469	0.000565	CcSEcCtD
Emtricitabine—DCK—Metabolism—PSMA5—osteoporosis	0.000469	0.0031	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PSMA2—osteoporosis	0.000469	0.0031	CbGpPWpGaD
Emtricitabine—Body temperature increased—Estradiol—osteoporosis	0.000467	0.000563	CcSEcCtD
Emtricitabine—Abdominal pain—Estradiol—osteoporosis	0.000467	0.000563	CcSEcCtD
Emtricitabine—Rash—Conjugated Estrogens—osteoporosis	0.000465	0.000561	CcSEcCtD
Emtricitabine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000465	0.00056	CcSEcCtD
Emtricitabine—Headache—Conjugated Estrogens—osteoporosis	0.000462	0.000557	CcSEcCtD
Emtricitabine—Nausea—Zoledronate—osteoporosis	0.000455	0.000549	CcSEcCtD
Emtricitabine—Nausea—Conjugated Estrogens—osteoporosis	0.000439	0.000528	CcSEcCtD
Emtricitabine—Hypersensitivity—Estradiol—osteoporosis	0.000435	0.000524	CcSEcCtD
Emtricitabine—Asthenia—Estradiol—osteoporosis	0.000424	0.000511	CcSEcCtD
Emtricitabine—Pruritus—Estradiol—osteoporosis	0.000418	0.000504	CcSEcCtD
Emtricitabine—Diarrhoea—Estradiol—osteoporosis	0.000404	0.000487	CcSEcCtD
Emtricitabine—Dizziness—Estradiol—osteoporosis	0.000391	0.000471	CcSEcCtD
Emtricitabine—DCK—Metabolism—CYP19A1—osteoporosis	0.000381	0.00251	CbGpPWpGaD
Emtricitabine—Vomiting—Estradiol—osteoporosis	0.000376	0.000453	CcSEcCtD
Emtricitabine—Rash—Estradiol—osteoporosis	0.000373	0.000449	CcSEcCtD
Emtricitabine—Dermatitis—Estradiol—osteoporosis	0.000372	0.000448	CcSEcCtD
Emtricitabine—Headache—Estradiol—osteoporosis	0.00037	0.000446	CcSEcCtD
Emtricitabine—Nausea—Estradiol—osteoporosis	0.000351	0.000423	CcSEcCtD
Emtricitabine—DCK—Metabolism—ADCY5—osteoporosis	0.000311	0.00205	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—GPX1—osteoporosis	0.00031	0.00205	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—MTHFR—osteoporosis	0.000286	0.00189	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—POMC—osteoporosis	0.000229	0.00151	CbGpPWpGaD
